These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4007736)
21. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1). Walshe JM Prog Clin Biol Res; 1979; 34():271-80. PubMed ID: 531055 [No Abstract] [Full Text] [Related]
22. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)]. Pierzchała W; Zamłyński J; Rzempołuch J Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826 [TBL] [Abstract][Full Text] [Related]
23. [Wilson's disease (hepatolenticular degeneration)]. Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518 [No Abstract] [Full Text] [Related]
24. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Walshe JM Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043 [No Abstract] [Full Text] [Related]
25. Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease. Soong YK; Huang HY; Huang CC; Chu NS J Formos Med Assoc; 1991 Jul; 90(7):693-6. PubMed ID: 1681022 [TBL] [Abstract][Full Text] [Related]
26. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine]. D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825 [No Abstract] [Full Text] [Related]
27. Hepatolenticular degeneration (Wilson's disease). Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427 [No Abstract] [Full Text] [Related]
28. [Hepatic changes in the neurological form of Wilson's disease]. Hauftová D; Hartl J; Slavícek J; Valach V; Fialová J; Pojerová M Vnitr Lek; 1967 Nov; 13(11):1064-9. PubMed ID: 6081668 [No Abstract] [Full Text] [Related]
30. [Hepatocerebral degeneration (Wilson's disease). 2. Therapy]. Werner T; Weinmann H Med Klin; 1965 Nov; 60(46):1856-9. PubMed ID: 5884683 [No Abstract] [Full Text] [Related]
31. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine]. Gregersen G; Frederiksen G Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040 [No Abstract] [Full Text] [Related]
32. [Physiopathological and therapeutic considerations on a case of Wilson's disease]. Di Simone A; Manacorda A Omnia Med Ther; 1968; 46(4):795-814. PubMed ID: 5743244 [No Abstract] [Full Text] [Related]
33. [Experiences with long-term therapy of Wilson's disease]. Schindler H Wien Z Inn Med; 1967; 48(12):465-9. PubMed ID: 5620587 [No Abstract] [Full Text] [Related]
34. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease. Chan CY; Baker AL Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662 [TBL] [Abstract][Full Text] [Related]
35. [Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)]. Vokrouhlická-RösslerovI ; Vodicková L; Neruda O Vnitr Lek; 1967 Oct; 13(10):1018-22. PubMed ID: 5630545 [No Abstract] [Full Text] [Related]
36. [Pemphigus in a patient treated with penicillamine for Wilson's disease]. Degos R; Touraine R; Belaïch S; Revuz J Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189 [No Abstract] [Full Text] [Related]